BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20219917)

  • 21. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
    Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The linking regions of EBNA1 are essential for its support of replication and transcription.
    Mackey D; Sugden B
    Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance.
    Dheekollu J; Wiedmer A; Ayyanathan K; Deakyne JS; Messick TE; Lieberman PM
    Cell; 2021 Feb; 184(3):643-654.e13. PubMed ID: 33482082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
    Chen YL; Liu CD; Cheng CP; Zhao B; Hsu HJ; Shen CL; Chiu SJ; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):243-8. PubMed ID: 24344309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication.
    Avolio-Hunter TM; Frappier L
    Virology; 2003 Oct; 315(2):398-408. PubMed ID: 14585343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr Virus Viral Processivity Factor EA-D Facilitates Virus Lytic Replication by Inducing Poly(ADP-Ribose) Polymerase 1 Degradation.
    Lee S; Kim J; Chung WC; Han JH; Song MJ
    J Virol; 2022 Nov; 96(21):e0037122. PubMed ID: 36286483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    Wysokenski DA; Yates JL
    J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.
    Sears J; Kolman J; Wahl GM; Aiyar A
    J Virol; 2003 Nov; 77(21):11767-80. PubMed ID: 14557661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EBNA1 and host factors in Epstein-Barr virus latent DNA replication.
    Frappier L
    Curr Opin Virol; 2012 Dec; 2(6):733-9. PubMed ID: 23031715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.
    Längle-Rouault F; Patzel V; Benavente A; Taillez M; Silvestre N; Bompard A; Sczakiel G; Jacobs E; Rittner K
    J Virol; 1998 Jul; 72(7):6181-5. PubMed ID: 9621086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).
    Lu F; Wikramasinghe P; Norseen J; Tsai K; Wang P; Showe L; Davuluri RV; Lieberman PM
    Virol J; 2010 Oct; 7():262. PubMed ID: 20929547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
    Shirakata M; Imadome KI; Hirai K
    Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.
    Shire K; Ceccarelli DF; Avolio-Hunter TM; Frappier L
    J Virol; 1999 Apr; 73(4):2587-95. PubMed ID: 10074103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes.
    Sears J; Ujihara M; Wong S; Ott C; Middeldorp J; Aiyar A
    J Virol; 2004 Nov; 78(21):11487-505. PubMed ID: 15479791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.
    Bashaw JM; Yates JL
    J Virol; 2001 Nov; 75(22):10603-11. PubMed ID: 11602702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.
    Sarkari F; Sanchez-Alcaraz T; Wang S; Holowaty MN; Sheng Y; Frappier L
    PLoS Pathog; 2009 Oct; 5(10):e1000624. PubMed ID: 19834552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of minimal oriP of Epstein-Barr virus required for DNA replication.
    Shirakata M; Hirai K
    J Biochem; 1998 Jan; 123(1):175-81. PubMed ID: 9504426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
    Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.